Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “WHO Grade III Oligodendroglial Tumor”

244 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 244 results

Early research (Phase 1)Ended earlyNCT02168270
What this trial is testing

Temozolomide and Ascorbic Acid in Treating Patients With Recurrent High-Grade Glioma

Who this might be right for
Anaplastic AstrocytomaAnaplastic OligodendrogliomaAnaplastic Oligoastrocytoma+2 more
University of Nebraska 4
Not applicableStudy completedNCT01009307
What this trial is testing

Study of Blood and Cheek Cell Samples From Patients With Glioma

Who this might be right for
Brain and Central Nervous System Tumors
University of California, San Francisco 1,709
Testing effectiveness (Phase 2)Study completedNCT00352521
What this trial is testing

Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) With Bevacizumab and Irinotecan for Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Duke University 20
Early research (Phase 1)Study completedNCT00075894
What this trial is testing

Alanosine in Treating Patients With Progressive or Recurrent Malignant Gliomas

Who this might be right for
Brain and Central Nervous System Tumors
National Cancer Institute (NCI) 18
Not applicableStudy completedNCT04708548
What this trial is testing

Long Term Implications of Rare Brain Tumours'

Who this might be right for
Quality of LifeCognitive ImpairmentWHO Grade II Oligodendroglial Tumor+3 more
Galina Velikova 267
Testing effectiveness (Phase 2)Ended earlyNCT01095094
What this trial is testing

Ritonavir and Lopinavir in Treating Patients With Progressive or Recurrent High-Grade Glioma

Who this might be right for
Brain TumorAnaplastic AstrocytomaAnaplastic Ependymoma+6 more
Case Comprehensive Cancer Center 19
Testing effectiveness (Phase 2)Study completedNCT00629889
What this trial is testing

Levetiracetam or Pregabalin in Treating Seizures in Patients Undergoing Chemotherapy and/or Radiation Therapy For Primary Brain Tumors

Who this might be right for
Brain and Central Nervous System TumorsSeizure
Dr Andrea Rossetti 52
Testing effectiveness (Phase 2)Study completedNCT00045110
What this trial is testing

Erlotinib in Treating Patients With Recurrent Malignant Glioma or Recurrent or Progressive Meningioma

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic OligodendrogliomaAdult Giant Cell Glioblastoma+6 more
National Cancer Institute (NCI) 136
Testing effectiveness (Phase 2)Study completedNCT00400816
What this trial is testing

Temozolomide in Treating Patients With Newly Diagnosed Anaplastic Oligodendroglioma or Mixed Oligoastrocytoma

Who this might be right for
Central Nervous System TumorsBrain Tumor
The Cleveland Clinic 29
Early research (Phase 1)Ended earlyNCT01378481
What this trial is testing

High-Dose Vorinostat and Fractionated Stereotactic Body Radiation Therapy in Treating Patients With Recurrent Glioma

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic OligodendrogliomaAdult Giant Cell Glioblastoma+4 more
National Cancer Institute (NCI) 30
Early research (Phase 1)Active Not RecruitingNCT02192359
What this trial is testing

Carboxylesterase-Expressing Allogeneic Neural Stem Cells and Irinotecan Hydrochloride in Treating Patients With Recurrent High-Grade Gliomas

Who this might be right for
Recurrent Anaplastic AstrocytomaRecurrent Anaplastic OligoastrocytomaRecurrent Anaplastic Oligodendroglioma+4 more
City of Hope Medical Center 18
Not applicableStudy completedNCT00376818
What this trial is testing

Stress Reduction Program in Patients With Malignant Brain Tumors and Their Family Caregivers

Who this might be right for
Brain and Central Nervous System TumorsPsychosocial Effects of Cancer and Its Treatment
Case Comprehensive Cancer Center 4
Early research (Phase 1)Study completedNCT02644291
What this trial is testing

Phase I Study of Mebendazole Therapy for Recurrent/Progressive Pediatric Brain Tumors

Who this might be right for
MedulloblastomaAstrocytoma, Grade IIIGlioblastoma+5 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 16
Early research (Phase 1)Study completedNCT00612651
What this trial is testing

PH I Addition of Farnesyl Transferase Inhibitor to Temozolomide for Pts w Gr 3 & 4 Malignant Gliomas

Who this might be right for
GliosarcomaGlioblastomaAnaplastic Astrocytoma
Duke University 37
Testing effectiveness (Phase 2)UnknownNCT00276783
What this trial is testing

Pemetrexed Disodium in Treating Patients With Recurrent Malignant Gliomas, Primary CNS Lymphoma, or Brain Metastases

Who this might be right for
Brain and Central Nervous System TumorsLymphomaMetastatic Cancer
Northwestern University 31
Testing effectiveness (Phase 2)Ended earlyNCT00389090
What this trial is testing

A Phase II Study of Temozolomide and O6-Benzylguanine (O6-BG) in Patients With Temozolomide-Resistant Anaplastic Glioma

Who this might be right for
GliomaAstrocytomaOligodendroglioma+1 more
Keryx / AOI Pharmaceuticals, Inc. 32
Testing effectiveness (Phase 2)Study completedNCT00003101
What this trial is testing

Combination Chemotherapy and Bone Marrow Transplantation or Peripheral Stem Cell Transplantation in Treating Patients With Oligodendroglioma

Who this might be right for
Brain and Central Nervous System Tumors
Memorial Sloan Kettering Cancer Center 60
Early research (Phase 1)Study completedNCT00003876
What this trial is testing

Internal Radiation Therapy Plus Carmustine Implants in Treating Patients With Recurrent or Refractory Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Barrett Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT05737212
What this trial is testing

Studying the Safety, Efficacy, and Pharmacokinetic Characteristics of BNCT in Patients With Recurrent High-grade Gliomas

Who this might be right for
Recurrent High-grade GliomaRecurrent GlioblastomaRecurrent Anaplastic Astrocytoma+1 more
Dawonmedax Co., Ltd. 7
Testing effectiveness (Phase 2)Study completedNCT00047281
What this trial is testing

Thalidomide, Celecoxib, and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Dana-Farber Cancer Institute
Load More Results